Shedir Pharma Group S.p.A.

BIT:SHE Stock Report

Market Cap: €55.4m

Shedir Pharma Group Future Growth

Future criteria checks 3/6

Shedir Pharma Group is forecast to grow earnings and revenue by 7.9% and 6.3% per annum respectively. EPS is expected to grow by 7.8% per annum. Return on equity is forecast to be 12.7% in 3 years.

Key information

7.9%

Earnings growth rate

7.8%

EPS growth rate

Pharmaceuticals earnings growth14.5%
Revenue growth rate6.3%
Future return on equity12.7%
Analyst coverage

Low

Last updated15 Oct 2024

Recent future growth updates

Recent updates

Shedir Pharma Group S.p.A.'s (BIT:SHE) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Nov 08
Shedir Pharma Group S.p.A.'s (BIT:SHE) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Shedir Pharma Group's (BIT:SHE) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 05
Shedir Pharma Group's (BIT:SHE) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Why Shedir Pharma Group's (BIT:SHE) Earnings Are Better Than They Seem

Oct 05
Why Shedir Pharma Group's (BIT:SHE) Earnings Are Better Than They Seem

Is Shedir Pharma Group (BIT:SHE) Using Too Much Debt?

Apr 06
Is Shedir Pharma Group (BIT:SHE) Using Too Much Debt?

What Type Of Returns Would Shedir Pharma Group's(BIT:SHE) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 30
What Type Of Returns Would Shedir Pharma Group's(BIT:SHE) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Earnings and Revenue Growth Forecasts

BIT:SHE - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202776810131
12/31/202672710121
12/31/20256878111
12/31/20246469111
6/30/202461669N/A
3/31/202460615N/A
12/31/2023596-41N/A
9/30/2023596-30N/A
6/30/2023586-20N/A
3/31/202356601N/A
12/31/202253613N/A
9/30/202251557N/A
6/30/20224941011N/A
3/31/20224741012N/A
12/31/20214541012N/A
9/30/2021444810N/A
6/30/202143379N/A
3/31/202143489N/A
12/31/2020434910N/A
9/30/202044357N/A
6/30/202045313N/A
3/31/2020473-4-1N/A
12/31/2019513-5-3N/A
9/30/2019504-3-1N/A
6/30/2019495-10N/A
3/31/201949667N/A
12/31/2018477-3-1N/A
12/31/2017403N/A5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SHE's forecast earnings growth (7.9% per year) is above the savings rate (2.5%).

Earnings vs Market: SHE's earnings (7.9% per year) are forecast to grow faster than the Italian market (6.7% per year).

High Growth Earnings: SHE's earnings are forecast to grow, but not significantly.

Revenue vs Market: SHE's revenue (6.3% per year) is forecast to grow faster than the Italian market (4.1% per year).

High Growth Revenue: SHE's revenue (6.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SHE's Return on Equity is forecast to be low in 3 years time (12.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/21 22:57
End of Day Share Price 2025/01/21 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shedir Pharma Group S.p.A. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gian GadiniBanca Akros S.p.A. (ESN)
Maria Di GradoKT & Partners Srl